Profile
Arvinder Dhalla is currently Vice President-Clinical Operations at Rani Therapeutics LLC and Vice President-Clinical Development at Rani Therapeutics Holdings, Inc. Formerly, Dr. Dhalla was Biology Director-Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Education includes a doctorate from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Arvinder Dhalla active positions
| Companies | Position | Start |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2021-06-30 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Chief Operating Officer | - |
Former positions of Arvinder Dhalla
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2014-12-31 |
Education of Arvinder Dhalla
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panjab University Chandigarh
Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
- Stock Market
- Insiders
- Arvinder Dhalla
















